Onesource Specialty Pharma Announces Board Meeting to Review Q1 Results and Updates Insider Trading Window
Onesource Specialty Pharma Limited has scheduled its Board of Directors meeting to review the unaudited financial results for the quarter ended June 30, 2026. The board meeting is set for Friday, July 24, 2026, with the aim of considering and approving the standalone and consolidated unaudited financial results, among other matters.In addition to the upcoming review, the company has provided updates regarding the trading status for Designated Persons in compliance with its Code of Conduct.
According to the company's procedures, the trading window for Designated Persons related to the quarter ended June 30, 2026, closed on July 01, 2026. The trading window is set to reopen after a period of 48 hours following the dissemination of the financial results by Onesource Specialty Pharma Limited.
This information relates to the management and corporate governance activities of Onesource Specialty Pharma Ltd. concerning its recent financial performance and adherence to internal protocols for insider trading.
ONESOURCE Stock Price Movement
Onesource Specialty Pharma Limited saw its stock price edge higher today, settling at ₹1693.9 after gaining 1.92%. The strong close was supported by robust trading activity, as 372,698 shares were traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.